Edwards Lifesciences CorporationEWNYSE
Loading
EW Revenue Growth (YoY Quarterly)•+13.26%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+13.26%
-1.4pp
+12.38%
+1.6pp
-72.48%
-62.9pp
+18.46%
-2.8pp
-76.35%
+14.2pp
-75.38%
+14.9pp
-75.38%
+14.9pp
-1.59%
+0.5pp
-1.47%
+0.6pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +9.43% | +6.23% | +10.56% | +14.67% | +13.26% |
| Gross Profit Growth | +7.70% | +6.77% | +9.33% | +10.82% | +12.38% |
| EBITDA Growth | +19.76% | +14.84% | -6.10% | -9.61% | -72.48% |
| Operating Income Growth | -12.36% | +11.05% | +18.15% | +21.25% | +18.46% |
| Net Income Growth | +4.24% | +1.73% | -9.32% | -90.52% | -76.35% |
| EPS Growth | +6.56% | +5.17% | -6.56% | -90.27% | -75.38% |
| EPS Diluted Growth | +6.56% | +5.17% | -8.20% | -90.25% | -75.38% |
| Weighted Average Shares Growth | -2.54% | -2.44% | -2.51% | -2.09% | -1.59% |
| Weighted Average Shares Diluted Growth | -2.70% | -2.70% | -2.71% | -2.07% | -1.47% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -193.34% | +0.00% | -21.88% | +63.08% | +0.00% |
| Free Cash Flow Growth | -606.57% | +0.00% | -15.80% | +61.36% | +0.00% |
| Receivables Growth | -12.16% | -14.25% | +8.17% | +10.02% | +25.39% |
| Inventory Growth | +20.28% | -7.74% | +11.42% | +3.32% | +3.63% |
| Asset Growth | +39.43% | +33.75% | +33.56% | +2.32% | +4.92% |
| Book Value per Share Growth | +54.28% | +45.86% | +45.43% | +9.19% | +5.07% |
| Debt Growth | +2.17% | +0.03% | +1.39% | -0.91% | +0.77% |
| R&D Expense Growth | +11.98% | -0.82% | +1.32% | +10.77% | -1.25% |
| SG&A Expenses Growth | +18.07% | +8.71% | +11.36% | +22.12% | +22.57% |
1 / 4